M&A
Lilly Completes Acquisition of Loxo Oncology
Eli Lilly and Company
PR-M02-19-NI-041Feb 20, 2019
Oncology
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
Eli Lilly and Company
PR-M01-19-NI-067Jan 23, 2019
Appointment
New Lilly Oncology President Selected
Nice Insight
PAO-M09-18-NI-002Sep 06, 2018